NO843043L - Fremgangsmaate for fremstilling av forbindelser med histamin h2-antagonistvirkning - Google Patents

Fremgangsmaate for fremstilling av forbindelser med histamin h2-antagonistvirkning

Info

Publication number
NO843043L
NO843043L NO843043A NO843043A NO843043L NO 843043 L NO843043 L NO 843043L NO 843043 A NO843043 A NO 843043A NO 843043 A NO843043 A NO 843043A NO 843043 L NO843043 L NO 843043L
Authority
NO
Norway
Prior art keywords
formula
compound
group
compounds
piperidinomethyl
Prior art date
Application number
NO843043A
Other languages
English (en)
Norwegian (no)
Inventor
Thomas Henry Brown
David Tuddenham
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of NO843043L publication Critical patent/NO843043L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
NO843043A 1983-07-29 1984-07-27 Fremgangsmaate for fremstilling av forbindelser med histamin h2-antagonistvirkning NO843043L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838320505A GB8320505D0 (en) 1983-07-29 1983-07-29 Chemical compounds

Publications (1)

Publication Number Publication Date
NO843043L true NO843043L (no) 1985-01-30

Family

ID=10546495

Family Applications (1)

Application Number Title Priority Date Filing Date
NO843043A NO843043L (no) 1983-07-29 1984-07-27 Fremgangsmaate for fremstilling av forbindelser med histamin h2-antagonistvirkning

Country Status (21)

Country Link
EP (1) EP0134096B1 (ja)
JP (1) JPS6051179A (ja)
KR (1) KR850001174A (ja)
AT (1) ATE40552T1 (ja)
AU (1) AU564650B2 (ja)
CA (1) CA1261831A (ja)
CS (1) CS244448B2 (ja)
DD (1) DD216933A5 (ja)
DE (1) DE3476541D1 (ja)
DK (1) DK368284A (ja)
ES (1) ES534620A0 (ja)
FI (1) FI842976A (ja)
GB (1) GB8320505D0 (ja)
GR (1) GR82226B (ja)
HU (1) HUT34743A (ja)
IL (1) IL72491A0 (ja)
JO (1) JO1327B1 (ja)
NO (1) NO843043L (ja)
PT (1) PT78977B (ja)
ZA (1) ZA845820B (ja)
ZW (1) ZW11584A1 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772704A (en) * 1983-09-21 1988-09-20 Bristol-Myers Company 2,5-disubstituted-4(3H)-pyrimidones having histamine H2 -receptor antagonist activity
GB8421427D0 (en) * 1984-08-23 1984-09-26 Smith Kline French Lab Chemical compounds
US7423147B2 (en) 2004-03-31 2008-09-09 Janssen Pharmaceutical, N.V. Pyridine compounds as histamine H3 modulators
CA2653940C (en) 2006-05-30 2015-07-14 Janssen Pharmaceutica N.V. Substituted pyridyl amide compounds as modulators of the histamine h3 receptor
CA2706328C (en) 2007-11-20 2016-04-19 Janssen Pharmaceutica N.V. Cycloalkyloxy- and heterocycloalkyloxypyridine compounds as modulators of the histamine h3 receptor
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN151188B (ja) * 1978-02-13 1983-03-05 Smith Kline French Lab
ZA793443B (en) * 1978-07-26 1980-12-31 Glaxo Group Ltd Heterocyclic derivatives
US4496567A (en) * 1978-11-13 1985-01-29 Smith Kline & French Laboratories Limited Phenyl alkylaminopyrimidones
US4521418A (en) * 1979-02-21 1985-06-04 Smith Kline & French Laboratories Limited Guanidinothiazolyl derivatives
ZW21281A1 (en) * 1980-10-01 1981-11-18 Smith Kline French Lab Amine derivatives
NZ202797A (en) * 1981-12-28 1985-08-30 Lilly Co Eli Pyrimidine derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
DK368284D0 (da) 1984-07-27
ATE40552T1 (de) 1989-02-15
KR850001174A (ko) 1985-03-16
AU564650B2 (en) 1987-08-20
CS244448B2 (en) 1986-07-17
JPS6051179A (ja) 1985-03-22
ZA845820B (en) 1985-06-26
JO1327B1 (en) 1986-11-30
FI842976A0 (fi) 1984-07-26
ES8600254A1 (es) 1985-09-16
DK368284A (da) 1985-01-30
EP0134096A2 (en) 1985-03-13
PT78977B (en) 1986-06-05
DD216933A5 (de) 1985-01-02
EP0134096B1 (en) 1989-02-01
GB8320505D0 (en) 1983-09-01
HUT34743A (en) 1985-04-28
GR82226B (ja) 1984-12-13
IL72491A0 (en) 1984-11-30
PT78977A (en) 1984-08-01
EP0134096A3 (en) 1985-12-18
ZW11584A1 (en) 1985-04-17
FI842976A (fi) 1985-01-30
DE3476541D1 (de) 1989-03-09
AU3099184A (en) 1985-01-31
ES534620A0 (es) 1985-09-16
CS581084A2 (en) 1985-08-15
CA1261831A (en) 1989-09-26

Similar Documents

Publication Publication Date Title
US4524206A (en) 1-Heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl)piperazine derivatives
US4532252A (en) 3,5-Substituted-2-pyridylalkylamino compounds having histamine H1 -antagonist activity
FI66373C (fi) Foerfarande foer framstaellning av farmakologiskt verksamma n-xacyklyl-alkyl-piperidiner
RU1802811C (ru) Способ получени N-( @ -замещенный алкил)-N @ -(имидазол-4-ил)-гуанидина или его кислых аддитивных солей
US4377576A (en) 5-(Heterocyclic amino-propionyl)-5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-ones
US4694008A (en) Chemical compounds
NO843043L (no) Fremgangsmaate for fremstilling av forbindelser med histamin h2-antagonistvirkning
US4540699A (en) N-Substituted pyridinones having histamine H2 -antagonist activity
US4952589A (en) Pyridine compounds
US4738969A (en) Substituted aminopyridones and aminoquinolones having histamine H2 -receptor blocking activity
US4567176A (en) 4H-Imidazol-4-ones and their pharmaceutical use
CA1155842A (en) Compounds
EP0150205A1 (en) ad(pyridinyl)-2-pyrimidinyl bdureas useful as cardiotonics and preparation thereof
JPS6330903B2 (ja)
US5045550A (en) Substituted tetrahydropyridines as central nervous system agents
US4863936A (en) 3,5-Substituted-2-pyridyl-alkylaminocyclobutenediones having histamine h1 -antagonist activity
US5418235A (en) Aminoalkyl-substituted 5-mercaptothiazoles, the preparation and use thereof
NO830575L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidon-derivater.
DE2811477A1 (de) 1,2,4-triazin-5-on-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4571398A (en) Cytosine derivatives having histamine H2 -antagonist activity
US4337253A (en) 4,5-Dihydro-2-methyl-6-(4-pyridinyl)-3(2H)-pyridazinone and its use as a cardiotonic
GB2111988A (en) Benzo-fused heterocyclic compounds
NO148556B (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive triazinoner.
PL203255B1 (pl) Nowe pochodne arylosulfonyloamino-1,4,5,6-tetrahydropirymidyny oraz sposób ich wytwarzania